ProShares Ultra Nasdaq Biotechnology Shares to Split on Thursday, November 19th (NASDAQ:BIB)

Shares of ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) are scheduled to split on Thursday, November 19th. The 2-1 split was recently announced. The newly minted shares will be issued to shareholders after the market closes on Wednesday, November 18th.

ProShares Ultra Nasdaq Biotechnology Price Performance

Shares of BIB opened at $116.07 on Friday. The firm has a market cap of $102.14 million, a PE ratio of 20.68 and a beta of 1.25. The stock’s fifty day moving average price is $113.64 and its two-hundred day moving average price is $96.67. ProShares Ultra Nasdaq Biotechnology has a 1 year low of $73.12 and a 1 year high of $126.40.

Institutional Investors Weigh In On ProShares Ultra Nasdaq Biotechnology

A hedge fund recently bought a new position in ProShares Ultra Nasdaq Biotechnology stock. Capital Investment Advisors LLC purchased a new stake in ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 5,696 shares of the exchange traded fund’s stock, valued at approximately $658,000. Capital Investment Advisors LLC owned 0.68% of ProShares Ultra Nasdaq Biotechnology as of its most recent SEC filing.

About ProShares Ultra Nasdaq Biotechnology

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day.